Medically reviewed by
Fahad MawloodTurkey is a hub for pulmonary hypertension treatment, with Memorial Şişli Hospital, Memorial Ataşehir Hospital, and Anadolu Medical Center leading. These JCI-accredited facilities ensure quality and safety. Memorial Şişli Hospital, the first in Turkey with JCI accreditation, offers multidisciplinary treatment approaches.
Success rates for pulmonary hypertension treatments in Turkey are promising. Innovative procedures like pulmonary endarterectomy, balloon pulmonary angioplasty, and lung transplantation improve outcomes. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, provides American standards. Recent advancements include targeted therapies and gene therapy, with sildenafil showing efficacy in a study.
Germany stands out for pulmonary hypertension care by merging rapid diagnostic protocols with specialized pharmaceutical access. Major centers provide right heart catheterization and 6-minute walk tests for fast results. Patients benefit from multidisciplinary teams. These experts combine pulmonology and cardiology to stabilize pulmonary artery pressure.
Bookimed Expert Insight: Germany's university hospitals, such as Essen, treat 370,000+ patients annually. This massive patient volume allows doctors to gain deep experience with rare therapies. Choosing these high-capacity centers often ensures access to the latest clinical trials and innovative pulmonary treatments.
What patients say: Patients in Germany note the highly structured care and rapid start of tailored therapies. They appreciate the multidisciplinary teams that include psychologists for holistic support. Many report improved exercise tolerance and stabilized pressure within 6 to 12 months.
Spain leads in Pulmonary hypertension treatment with top clinics like Centro Médico Teknon, SJD Barcelona Children’s Hospital, and HM Hospitales. Accredited by the Joint Commission International, they offer procedures such as balloon pulmonary angioplasty, pulmonary endarterectomy, targeted medical therapy, and lung transplantation.
Spain's Pulmonary hypertension treatment success is notable, with survival rates around 90%. Centro Médico Teknon, SJD Barcelona Children’s Hospital, and HM Hospitales contribute significantly to these outcomes through advanced diagnostics and personalized care.
Italy is at the forefront of Pulmonary hypertension treatment, with renowned clinics such as San Donato Hospital, San Raffaele, and Maria Cecilia Hospital offering cutting-edge therapies. San Donato Hospital, known for its cardiology and cardiac surgery expertise, performs over 9,400 heart and vascular operations annually, making it the leading institution in the country. San Raffaele, a prominent research hospital in Milan, excels in cardiovascular surgery and conducts more than 52,000 operations each year. Maria Cecilia Hospital, accredited by Joint Commission International, is recognized for its advanced heart surgery techniques, handling over 15% of Italy's cardiac surgeries.
Innovative procedures such as balloon pulmonary angioplasty, pulmonary endarterectomy, heart-lung transplantation, and targeted medical therapies are some of the latest advancements in treating Pulmonary hypertension. The survival rate for patients undergoing these treatments in Italy stands at approximately 85%, with success rates significantly improved due to the integration of precise diagnostics and personalized treatment plans.